Page last updated: 2024-10-16

benzene and Multiple Myeloma

benzene has been researched along with Multiple Myeloma in 40 studies

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research Excerpts

ExcerptRelevanceReference
"Epidemiologic studies have suggested that benzene exposure may be a risk factor of multiple myeloma (MM)."8.81Meta-analysis of multiple myeloma and benzene exposure. ( Imai, K; Ishida, T; Mori, M; Nagata, Y; Sonoda, T, 2001)
"Two case series and two epidemiological studies in the 1970s and 1980s suggested that benzene exposure might be a risk factor for multiple myeloma."8.79Does benzene cause multiple myeloma? An analysis of the published case-control literature. ( Bezabeh, S; Engel, A; Lamm, SH; Morris, CB, 1996)
"Case reports have suggested an association between benzene exposure and multiple myeloma."8.79Multiple myeloma and benzene exposure in a multinational cohort of more than 250,000 petroleum workers. ( Raabe, GK; Wong, O, 1997)
"While there is a general consensus about the ability of benzene to induce acute myeloid leukemia (AML), its effects on chronic lymphoid leukemia and multiple myeloma (MM) are still under debate."7.74Risk of leukemia and multiple myeloma associated with exposure to benzene and other organic solvents: evidence from the Italian Multicenter Case-control study. ( Amadori, D; Belletti, I; Benvenuti, A; Costantini, AS; Crosignani, P; Kriebel, D; Maltoni, SA; Mendico, I; Miceli, G; Miligi, L; Mirabelli, D; Ramazzotti, V; Rodella, S; Romeo, L; Sommani, L; Stagnaro, E; Tozzi, GA; Troschel, L; Tumino, R; Vineis, P, 2008)
"Case reports and epidemiological studies of workers exposed to benzene have demonstrated associations with a number of lymphohematopoietic diseases, but the association with multiple myeloma (MM) has been less apparent."7.73Benzene exposure and multiple myeloma: a detailed meta-analysis of benzene cohort studies. ( Infante, PF, 2006)
"To determine the risk of developing acute myeloid leukaemia (AML) and multiple myeloma in a cohort of workers exposed to benzene."7.69Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene. ( Wong, O, 1995)
"We assessed three study quality dimensions to evaluate the impact of study quality variations on meta-relative risks (mRRs): stratification by the year of start of follow-up, stratification by the strength of the reported acute myelogenous leukemia association, and stratification by the quality of benzene exposure assessment."4.87Occupational benzene exposure and the risk of lymphoma subtypes: a meta-analysis of cohort studies incorporating three study quality dimensions. ( Kromhout, H; Lan, Q; Rothman, N; Vermeulen, R; Vlaanderen, J, 2011)
"Epidemiologic studies have suggested that benzene exposure may be a risk factor of multiple myeloma (MM)."4.81Meta-analysis of multiple myeloma and benzene exposure. ( Imai, K; Ishida, T; Mori, M; Nagata, Y; Sonoda, T, 2001)
"Two case series and two epidemiological studies in the 1970s and 1980s suggested that benzene exposure might be a risk factor for multiple myeloma."4.79Does benzene cause multiple myeloma? An analysis of the published case-control literature. ( Bezabeh, S; Engel, A; Lamm, SH; Morris, CB, 1996)
"Case reports have suggested an association between benzene exposure and multiple myeloma."4.79Multiple myeloma and benzene exposure in a multinational cohort of more than 250,000 petroleum workers. ( Raabe, GK; Wong, O, 1997)
" An excess risk of liver and biliary tract cancers was suggested in the cohort with the high exposure to methylene chloride, but not found in the other cohorts where an excess risk of pancreatic cancer was suggested."4.79Organic solvents and cancer. ( Anttila, A; Hemminki, K; Lynge, E, 1997)
"Benzene, a common industrial chemical and a component of gasoline, is radiomimetic and exposure may lead progressively to aplastic anaemia, leukaemia, and multiple myeloma."4.78The toxicity of benzene and its metabolism and molecular pathology in human risk assessment. ( Anderson, D; Parke, DV; Yardley-Jones, A, 1991)
"While there is a general consensus about the ability of benzene to induce acute myeloid leukemia (AML), its effects on chronic lymphoid leukemia and multiple myeloma (MM) are still under debate."3.74Risk of leukemia and multiple myeloma associated with exposure to benzene and other organic solvents: evidence from the Italian Multicenter Case-control study. ( Amadori, D; Belletti, I; Benvenuti, A; Costantini, AS; Crosignani, P; Kriebel, D; Maltoni, SA; Mendico, I; Miceli, G; Miligi, L; Mirabelli, D; Ramazzotti, V; Rodella, S; Romeo, L; Sommani, L; Stagnaro, E; Tozzi, GA; Troschel, L; Tumino, R; Vineis, P, 2008)
"Benzene exposure has been shown to be related to acute myelogenous leukemia, while the association with multiple myeloma and non-Hodgkin lymphoma has been a much-debated issue."3.74Increased risk of acute myelogenous leukemia and multiple myeloma in a historical cohort of upstream petroleum workers exposed to crude oil. ( Bråtveit, M; Kirkeleit, J; Moen, BE; Riise, T, 2008)
"A nested case-control study found that the excess of leukemia, identified among the male members of the Health Watch cohort, was associated with benzene exposure."3.73Health Watch exposure estimates: do they underestimate benzene exposure? ( Gibbons, C; Glass, DC; Gray, CN; Jolley, DJ; Sim, MR, 2005)
"Case reports and epidemiological studies of workers exposed to benzene have demonstrated associations with a number of lymphohematopoietic diseases, but the association with multiple myeloma (MM) has been less apparent."3.73Benzene exposure and multiple myeloma: a detailed meta-analysis of benzene cohort studies. ( Infante, PF, 2006)
"Five new leukemia cases were observed in benzene-exposed white males, but the summary SMR for this group declined from 3."3.71Benzene exposure and hematopoietic mortality: A long-term epidemiologic risk assessment. ( Hornung, RW; Rinsky, RA; Silver, SR; Tseng, CY, 2002)
"The aim of this update on a cohort of male paint industry workers was to determine whether an excess of mortality and incidence of lymphatic and hematopoietic tumors, particularly multiple myeloma, still exists, and, if so, to determine if it is due to exposures occurring before the mid-1950s, when benzene disappeared as a solvent in the Swedish paint industry."3.70Mortality and cancer incidence among Swedish paint industry workers with long-term exposure to organic solvents. ( Lundberg, I; Milatou-Smith, R, 1998)
"To determine the risk of developing acute myeloid leukaemia (AML) and multiple myeloma in a cohort of workers exposed to benzene."3.69Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene. ( Wong, O, 1995)
"Risks of leukaemia, non-Hodgkin's lymphoma, and multiple myeloma were not associated with increasing cumulative exposure to benzene or total hydrocarbons."3.69Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers. ( Armstrong, TW; Huebner, WW; Katz, AM; Nicolich, MJ; Pearlman, ED; Schnatter, AR; Thompson, FS, 1996)
"7 cases of multiple myeloma with a history of exposure to benzene, radioactive iodine, chemotherapy for Hodgkin's disease and of repeated injections of autovaccine to Staphylococcus albus hemolyticus are described."3.67Clinical observations showing the role of some factors in the etiology of multiple myeloma. A study in 7 patients. ( Aksoy, M; Bakioğlu, I; Dinçol, G; Erdem, S; Hepyüksel, T; Kutlar, A, 1984)
"Today there seems to be sufficient data to incriminate benzene as a potent carcinogenic agent causing leukemia, malignant lymphoma, multiple myeloma and lung cancer, as well as numerous disorders of the bone marrow depression."3.67Benzene as a leukemogenic and carcinogenic agent. ( Aksoy, M, 1985)
"Discussion and synthesis of the animal cancer studies and mechanistic data related to specific cancers also were limited."2.47The IARC october 2009 evaluation of benzene carcinogenicity was incomplete and needs to be reconsidered. ( Infante, PF, 2011)
"Benzene has been used in various industries as glues or solvents in Korea."1.33Occupational exposure to benzene in South Korea. ( Ahn, YS; Kang, SK; Kim, TK; Lee, JO; Lee, MY, 2005)
"The leukemias were not restricted to acute myelogenous subtypes, and they occurred predominantly among workers hired before 1950 at exposure levels lower than previously reported."1.30Cancer mortality among workers with benzene exposure. ( Buckley, CF; Collins, JJ; Ireland, B; Riordan, SG, 1997)

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-19909 (22.50)18.7374
1990's13 (32.50)18.2507
2000's13 (32.50)29.6817
2010's4 (10.00)24.3611
2020's1 (2.50)2.80

Authors

AuthorsStudies
Nguépy Keubo, FR1
Mboua, PC1
Djifack Tadongfack, T1
Fokouong Tchoffo, E1
Tasson Tatang, C1
Ide Zeuna, J1
Noupoue, EM1
Tsoplifack, CB1
Folefack, GO1
Kettani, M1
Bandelier, P1
Huo, J1
Li, H4
Yu, D1
Arulsamy, N1
AlAbbad, S1
Sardot, T1
Lekashvili, O1
Decato, D1
Lelj, F1
Alexander Ross, JB1
Rosenberg, E1
Nazir, H1
Muthuswamy, N1
Louis, C1
Jose, S1
Prakash, J1
Buan, MEM1
Flox, C1
Chavan, S1
Shi, X1
Kauranen, P1
Kallio, T1
Maia, G1
Tammeveski, K1
Lymperopoulos, N1
Carcadea, E1
Veziroglu, E1
Iranzo, A1
M Kannan, A1
Arunamata, A1
Tacy, TA1
Kache, S1
Mainwaring, RD1
Ma, M1
Maeda, K1
Punn, R1
Noguchi, S1
Hahn, S3
Iwasa, Y3
Ling, J2
Voccio, JP2
Kim, Y3
Song, J3
Bascuñán, J2
Chu, Y1
Tomita, M1
Cazorla, M1
Herrera, E1
Palomeque, E1
Saud, N1
Hoplock, LB1
Lobchuk, MM1
Lemoine, J1
Li, X10
Henson, MA1
Unsihuay, D1
Qiu, J1
Swaroop, S1
Nagornov, KO1
Kozhinov, AN1
Tsybin, YO1
Kuang, S1
Laskin, J1
Zin, NNINM1
Mohamad, MN1
Roslan, K1
Abdul Wafi, S1
Abdul Moin, NI1
Alias, A1
Zakaria, Y1
Abu-Bakar, N1
Naveed, A1
Jilani, K1
Siddique, AB1
Akbar, M1
Riaz, M1
Mushtaq, Z1
Sikandar, M1
Ilyas, S1
Bibi, I1
Asghar, A1
Rasool, G1
Irfan, M1
Li, XY1
Zhao, S1
Fan, XH1
Chen, KP1
Hua, W1
Liu, ZM1
Xue, XD1
Zhou, B1
Zhang, S2
Xing, YL1
Chen, MA1
Sun, Y1
Neradilek, MB1
Wu, XT1
Zhang, D2
Huang, W1
Cui, Y1
Yang, QQ1
Li, HW1
Zhao, XQ1
Hossein Rashidi, B1
Tarafdari, A1
Ghazimirsaeed, ST1
Shahrokh Tehraninezhad, E1
Keikha, F1
Eslami, B1
Ghazimirsaeed, SM1
Jafarabadi, M1
Silvani, Y1
Lovita, AND1
Maharani, A1
Wiyasa, IWA1
Sujuti, H1
Ratnawati, R1
Raras, TYM1
Lemin, AS1
Rahman, MM1
Pangarah, CA1
Kiyu, A1
Zeng, C2
Du, H1
Lin, D1
Jalan, D1
Rubagumya, F1
Hopman, WM1
Vanderpuye, V1
Lopes, G1
Seruga, B1
Booth, CM1
Berry, S1
Hammad, N1
Sajo, EA1
Okunade, KS1
Olorunfemi, G1
Rabiu, KA1
Anorlu, RI1
Xu, C2
Xiang, Y1
Xu, X1
Zhou, L2
Dong, X1
Tang, S1
Gao, XC1
Wei, CH1
Zhang, RG1
Cai, Q1
He, Y1
Tong, F1
Dong, JH1
Wu, G1
Dong, XR1
Tang, X1
Tao, F1
Xiang, W1
Zhao, Y2
Jin, L1
Tao, H1
Lei, Y1
Gan, H1
Huang, Y1
Chen, Y3
Chen, L3
Shan, A1
Zhao, H2
Wu, M2
Ma, Q1
Wang, J4
Zhang, E1
Zhang, J3
Li, Y5
Xue, F1
Deng, L1
Liu, L2
Yan, Z2
Wang, Y2
Meng, J1
Chen, G2
Anastassiadou, M1
Bernasconi, G1
Brancato, A1
Carrasco Cabrera, L1
Greco, L1
Jarrah, S1
Kazocina, A1
Leuschner, R1
Magrans, JO1
Miron, I1
Nave, S1
Pedersen, R1
Reich, H1
Rojas, A1
Sacchi, A1
Santos, M1
Theobald, A1
Vagenende, B1
Verani, A1
Du, L1
Liu, X1
Ren, Y1
Li, J7
Li, P1
Jiao, Q1
Meng, P1
Wang, F2
Wang, YS1
Wang, C3
Zhou, X2
Wang, W1
Wang, S2
Hou, J1
Zhang, A1
Lv, B1
Gao, C1
Pang, D1
Lu, K1
Ahmad, NH1
Wang, L1
Zhu, J2
Zhang, L2
Zhuang, T1
Tu, J1
Zhao, Z1
Qu, Y1
Yao, H1
Wang, X5
Lee, DF1
Shen, J3
Wen, L1
Huang, G2
Xie, X1
Zhao, Q1
Hu, W1
Zhang, Y4
Wu, X1
Lu, J2
Li, M1
Li, W2
Wu, W1
Du, F1
Ji, H1
Yang, X2
Xu, Z1
Wan, L1
Wen, Q1
Cho, CH1
Zou, C1
Xiao, Z1
Liao, J1
Su, X1
Bi, Z1
Su, Q1
Huang, H1
Wei, Y2
Gao, Y2
Na, KJ1
Choi, H1
Oh, HR1
Kim, YH1
Lee, SB1
Jung, YJ1
Koh, J1
Park, S1
Lee, HJ1
Jeon, YK1
Chung, DH1
Paeng, JC1
Park, IK1
Kang, CH1
Cheon, GJ1
Kang, KW1
Lee, DS1
Kim, YT1
Pajuelo-Lozano, N1
Alcalá, S1
Sainz, B1
Perona, R1
Sanchez-Perez, I1
Logotheti, S1
Marquardt, S1
Gupta, SK1
Richter, C1
Edelhäuser, BAH1
Engelmann, D1
Brenmoehl, J1
Söhnchen, C1
Murr, N1
Alpers, M1
Singh, KP1
Wolkenhauer, O1
Heckl, D1
Spitschak, A1
Pützer, BM1
Liao, Y1
Cheng, J1
Kong, X1
Li, S1
Zhang, M4
Zhang, H1
Yang, T2
Dong, Y1
Xu, Y1
Yuan, Z1
Cao, J1
Zheng, Y1
Luo, Z1
Mei, Z1
Yao, Y1
Liu, Z2
Liang, C1
Yang, H1
Song, Y1
Yu, K1
Zhu, C1
Huang, Z1
Qian, J1
Ge, J1
Hu, J2
Wang, H2
Liu, Y4
Mi, Y1
Kong, H1
Xi, D1
Yan, W1
Luo, X1
Ning, Q1
Chang, X2
Zhang, T2
Wang, Q2
Rathore, MG1
Reddy, K1
Chen, H1
Shin, SH1
Ma, WY1
Bode, AM1
Dong, Z1
Mu, W1
Liu, C3
Gao, F1
Qi, Y1
Lu, H1
Zhang, X4
Cai, X1
Ji, RY1
Hou, Y3
Tian, J2
Shi, Y1
Ying, S1
Tan, M1
Feng, G1
Kuang, Y1
Chen, D1
Wu, D3
Zhu, ZQ1
Tang, HX1
Shi, ZE1
Kang, J1
Liu, Q1
Qi, J2
Mu, J1
Cong, Z1
Chen, S2
Fu, D1
Li, Z2
Celestrin, CP1
Rocha, GZ1
Stein, AM1
Guadagnini, D1
Tadelle, RM1
Saad, MJA1
Oliveira, AG1
Bianconi, V1
Bronzo, P1
Banach, M1
Sahebkar, A1
Mannarino, MR1
Pirro, M1
Patsourakos, NG1
Kouvari, M1
Kotidis, A1
Kalantzi, KI1
Tsoumani, ME1
Anastasiadis, F1
Andronikos, P1
Aslanidou, T1
Efraimidis, P1
Georgiopoulos, A1
Gerakiou, K1
Grigoriadou-Skouta, E1
Grigoropoulos, P1
Hatzopoulos, D1
Kartalis, A1
Lyras, A1
Markatos, G1
Mikrogeorgiou, A1
Myroforou, I1
Orkopoulos, A1
Pavlidis, P1
Petras, C1
Riga, M1
Skouloudi, M1
Smyrnioudis, N1
Thomaidis, K1
Tsikouri, GE1
Tsikouris, EI1
Zisimos, K1
Vavoulis, P1
Vitali, MG1
Vitsas, G1
Vogiatzidis, C1
Chantanis, S1
Fousas, S1
Panagiotakos, DB1
Tselepis, AD1
Jungen, C1
Alken, FA1
Eickholt, C1
Scherschel, K1
Kuklik, P1
Klatt, N1
Schwarzl, J1
Moser, J1
Jularic, M1
Akbulak, RO1
Schaeffer, B1
Willems, S1
Meyer, C1
Nowak, JK1
Szczepanik, M1
Trypuć, M1
Pogorzelski, A1
Bobkowski, W1
Grytczuk, M1
Minarowska, A1
Wójciak, R1
Walkowiak, J1
Lu, Y1
Xi, J1
Li, C1
Chen, W2
Hu, X1
Zhang, F1
Wei, H1
Wang, Z1
Gurzu, S1
Jung, I1
Sugimura, H2
Stefan-van Staden, RI1
Yamada, H1
Natsume, H1
Iwashita, Y1
Szodorai, R1
Szederjesi, J1
Yari, D1
Ehsanbakhsh, Z1
Validad, MH1
Langroudi, FH1
Esfandiari, H1
Prager, A1
Hassanpour, K1
Kurup, SP1
Mets-Halgrimson, R1
Yoon, H1
Zeid, JL1
Mets, MB1
Rahmani, B1
Araujo-Castillo, RV1
Culquichicón, C1
Solis Condor, R1
Efendi, F1
Sebayang, SK1
Astutik, E1
Hadisuyatmana, S1
Has, EMM1
Kuswanto, H1
Foroutan, T1
Ahmadi, F1
Moayer, F1
Khalvati, S1
Zhang, Q2
Lyu, Y1
Huang, J1
Yu, N1
Wen, Z1
Hou, H1
Zhao, T1
Gupta, A1
Khosla, N1
Govindasamy, V1
Saini, A1
Annapurna, K1
Dhakate, SR1
Akkaya, Ö1
Chandgude, AL1
Dömling, A1
Harnett, J1
Oakes, K1
Carè, J1
Leach, M1
Brown, D1
Cramer, H1
Pinder, TA1
Steel, A1
Anheyer, D1
Cantu, J1
Valle, J1
Flores, K1
Gonzalez, D1
Valdes, C1
Lopez, J1
Padilla, V1
Alcoutlabi, M1
Parsons, J1
Núñez, K1
Hamed, M1
Fort, D1
Bruce, D1
Thevenot, P1
Cohen, A1
Weber, P1
Menezes, AMB1
Gonçalves, H1
Perez-Padilla, R1
Jarvis, D1
de Oliveira, PD1
Wehrmeister, FC1
Mir, S1
Wong, J1
Ryan, CM1
Bellingham, G1
Singh, M2
Waseem, R1
Eckert, DJ1
Chung, F1
Hegde, H1
Shimpi, N1
Panny, A1
Glurich, I1
Christie, P1
Acharya, A1
English, KL1
Downs, M1
Goetchius, E1
Buxton, R1
Ryder, JW1
Ploutz-Snyder, R1
Guilliams, M1
Scott, JM1
Ploutz-Snyder, LL1
Martens, C1
Goplen, FK1
Aasen, T1
Gjestad, R1
Nordfalk, KF1
Nordahl, SHG1
Inoue, T1
Soshi, S1
Kubota, M1
Marumo, K1
Mortensen, NP1
Caffaro, MM1
Patel, PR2
Uddin, MJ1
Aravamudhan, S1
Sumner, SJ1
Fennell, TR1
Gal, RL1
Cohen, NJ1
Kruger, D1
Beck, RW1
Bergenstal, RM1
Calhoun, P1
Cushman, T1
Haban, A1
Hood, K1
Johnson, ML1
McArthur, T1
Olson, BA1
Weinstock, RS1
Oser, SM1
Oser, TK1
Bugielski, B1
Strayer, H1
Aleppo, G1
Maruyama, H1
Hirayama, K1
Yamashita, M1
Ohgi, K1
Tsujimoto, R1
Takayasu, M1
Shimohata, H1
Kobayashi, M1
Buscagan, TM1
Rees, DC1
Jaborek, JR1
Zerby, HN1
Wick, MP1
Fluharty, FL1
Moeller, SJ1
Razavi, P1
Dickler, MN1
Shah, PD1
Toy, W1
Brown, DN1
Won, HH1
Li, BT1
Shen, R1
Vasan, N1
Modi, S1
Jhaveri, K1
Caravella, BA1
Patil, S1
Selenica, P1
Zamora, S1
Cowan, AM1
Comen, E1
Singh, A1
Covey, A1
Berger, MF1
Hudis, CA1
Norton, L1
Nagy, RJ1
Odegaard, JI1
Lanman, RB1
Solit, DB1
Robson, ME1
Lacouture, ME1
Brogi, E1
Reis-Filho, JS1
Moynahan, ME1
Scaltriti, M1
Chandarlapaty, S1
Papouskova, K1
Moravcova, M1
Masrati, G1
Ben-Tal, N1
Sychrova, H1
Zimmermannova, O1
Fang, J1
Fan, Y1
Luo, T2
Su, H1
Tsetseris, L1
Anthopoulos, TD1
Liu, SF1
Zhao, K1
Sacan, O1
Turkyilmaz, IB1
Bayrak, BB1
Mutlu, O1
Akev, N1
Yanardag, R1
Gruber, S1
Kamnoedboon, P1
Özcan, M1
Srinivasan, M1
Jo, YH1
Oh, HK1
Jeong, SY1
Lee, BG1
Zheng, J1
Guan, H1
Li, D2
Tan, H1
Maji, TK1
J R, A1
Mukherjee, S1
Alexander, R1
Mondal, A1
Das, S1
Sharma, RK1
Chakraborty, NK1
Dasgupta, K1
Sharma, AMR1
Hawaldar, R1
Pandey, M1
Naik, A1
Majumdar, K1
Pal, SK1
Adarsh, KV1
Ray, SK1
Karmakar, D1
Ma, Y2
Gao, W1
Ma, S1
Lin, W1
Zhou, T1
Wu, T1
Wu, Q1
Ye, C1
He, X1
Jiang, F1
Yuan, D1
Chen, Q1
Hong, M1
Chen, K1
Hussain, M1
Razi, SS1
Yildiz, EA1
Zhao, J1
Yaglioglu, HG1
Donato, MD1
Jiang, J1
Jamil, MI1
Zhan, X1
Chen, F1
Cheng, D1
Wu, CT1
Utsunomiya, T1
Ichii, T1
Fujinami, S1
Nakajima, K1
Sanchez, DM1
Raucci, U1
Ferreras, KN1
Martínez, TJ1
Mordi, NA1
Mordi, IR1
Singh, JS1
McCrimmon, RJ1
Struthers, AD1
Lang, CC1
Wang, XW1
Yuan, LJ1
Yang, Y1
Chen, WF1
Luo, R1
Yang, K1
Amarasiri, SS1
Attanayake, AP1
Arawwawala, LDAM1
Jayatilaka, KAPW1
Mudduwa, LKB1
Ogunsuyi, O2
Akanni, O1
Alabi, O1
Alimba, C1
Adaramoye, O1
Cambier, S1
Eswara, S1
Gutleb, AC1
Bakare, A1
Gu, Z1
Cong, J1
Pellegrini, M1
Palmieri, S1
Ricci, A1
Serio, A1
Paparella, A1
Lo Sterzo, C1
Jadeja, SD1
Vaishnav, J1
Mansuri, MS1
Shah, C1
Mayatra, JM1
Shah, A1
Begum, R1
Song, H2
Lian, Y1
Wan, T1
Schultz-Lebahn, A1
Skipper, MT1
Hvas, AM1
Larsen, OH1
Hijazi, Z1
Granger, CB1
Hohnloser, SH1
Westerbergh, J1
Lindbäck, J1
Alexander, JH1
Keltai, M1
Parkhomenko, A1
López-Sendón, JL1
Lopes, RD1
Siegbahn, A1
Wallentin, L1
El-Tarabany, MS1
Saleh, AA1
El-Araby, IE1
El-Magd, MA1
van Ginkel, MPH1
Schijven, MP1
van Grevenstein, WMU1
Schreuder, HWR1
Pereira, EDM1
da Silva, J1
Carvalho, PDS1
Grivicich, I1
Picada, JN1
Salgado Júnior, IB1
Vasques, GJ1
Pereira, MADS1
Reginatto, FH1
Ferraz, ABF1
Vasilenko, EA1
Gorshkova, EN1
Astrakhantseva, IV1
Drutskaya, MS1
Tillib, SV1
Nedospasov, SA1
Mokhonov, VV1
Nam, YW1
Cui, M1
Orfali, R1
Viegas, A1
Nguyen, M1
Mohammed, EHM1
Zoghebi, KA1
Rahighi, S1
Parang, K1
Patterson, KC1
Kahanovitch, U1
Gonçalves, CM1
Hablitz, JJ1
Staruschenko, A1
Mulkey, DK1
Olsen, ML1
Gu, L1
Cao, X1
Mukhtar, A1
Wu, K1
Zhang, YY1
Zhu, Y1
Lu, DZ1
Dong, W1
Bi, WJ1
Feng, XJ1
Wen, LM1
Sun, H1
Qi, MC1
Chang, CC1
Dinh, TK1
Lee, YA1
Wang, FN1
Sung, YC1
Yu, PL1
Chiu, SC1
Shih, YC1
Wu, CY1
Huang, YD1
Lu, TT1
Wan, D1
Sakizadeh, J1
Cline, JP1
Snyder, MA1
Kiely, CJ1
McIntosh, S1
Jiang, X1
Cao, JW1
Zhao, CK1
Yang, R1
Zhang, QY1
Chen, KJ2
Liu, H1
He, Z1
Chen, B1
Wu, J1
Du, X1
Moore, J1
Blank, BR1
Eksterowicz, J1
Sutimantanapi, D1
Yuen, N1
Metzger, T1
Chan, B1
Huang, T1
Chen, X1
Duong, F1
Kong, W1
Chang, JH1
Sun, J1
Zavorotinskaya, T1
Ye, Q1
Junttila, MR1
Ndubaku, C1
Friedman, LS1
Fantin, VR1
Sun, D1
Fei, P1
Xie, Q1
Jiang, Y1
Feng, H1
Chang, Y1
Kang, H1
Xing, M1
Chen, J1
Shao, Z1
Yuan, C1
Wu, Y1
Allan, R1
Canham, K1
Wallace, R1
Singh, D1
Ward, J1
Cooper, A1
Newcomb, C1
Nammour, S1
El Mobadder, M1
Maalouf, E1
Namour, M1
Namour, A1
Rey, G1
Matamba, P1
Matys, J1
Zeinoun, T1
Grzech-Leśniak, K1
Segabinazi Peserico, C1
Garozi, L1
Zagatto, AM1
Machado, FA1
Hirth, JM1
Dinehart, EE1
Lin, YL1
Kuo, YF1
Nouri, SS1
Ritchie, C1
Volow, A1
Li, B2
McSpadden, S1
Dearman, K1
Kotwal, A1
Sudore, RL1
Ward, L1
Thakur, A1
Kondadasula, SV1
Ji, K1
Schalk, DL1
Bliemeister, E1
Ung, J1
Aboukameel, A1
Casarez, E1
Sloane, BF1
Lum, LG1
Xiao, M1
Feng, X1
Gao, R1
Du, B1
Brooks, T1
Zwirner, J1
Hammer, N1
Ondruschka, B1
Jermy, M1
Luengo, A1
Marzo, I1
Reback, M1
Daubit, IM1
Fernández-Moreira, V1
Metzler-Nolte, N1
Gimeno, MC1
Tonchev, I1
Heberman, D1
Peretz, A1
Medvedovsky, AT1
Gotsman, I1
Rashi, Y1
Poles, L1
Goland, S1
Perlman, GY1
Danenberg, HD1
Beeri, R1
Shuvy, M1
Fu, Q1
Yang, D1
Sarapulova, A1
Pang, Q1
Meng, Y1
Wei, L1
Ehrenberg, H1
Kim, CC1
Jeong, SH1
Oh, KH1
Nam, KT1
Sun, JY1
Ning, J1
Duan, Z1
Kershaw, SV1
Rogach, AL1
Gao, Z1
Wang, T1
Li, Q1
Cao, T1
Guo, L1
Fu, Y1
Seeger, ZL1
Izgorodina, EI1
Hue, S1
Beldi-Ferchiou, A1
Bendib, I1
Surenaud, M1
Fourati, S1
Frapard, T1
Rivoal, S1
Razazi, K1
Carteaux, G1
Delfau-Larue, MH1
Mekontso-Dessap, A1
Audureau, E1
de Prost, N1
Gao, SS1
Duangthip, D1
Lo, ECM1
Chu, CH1
Roberts, W1
Rosenheck, RA1
Miyake, T1
Kimoto, E1
Luo, L1
Mathialagan, S1
Horlbogen, LM1
Ramanathan, R1
Wood, LS1
Johnson, JG1
Le, VH1
Vourvahis, M1
Rodrigues, AD1
Muto, C1
Furihata, K1
Sugiyama, Y1
Kusuhara, H1
Gong, Q1
Song, W1
Sun, B1
Cao, P1
Gu, S1
Sun, X1
Zhou, G1
Toma, C1
Khandhar, S1
Zalewski, AM1
D'Auria, SJ1
Tu, TM1
Jaber, WA1
Cho, J2
Suwandaratne, NS1
Razek, S1
Choi, YH1
Piper, LFJ1
Watson, DF1
Banerjee, S1
Xie, S1
Lindsay, AP1
Bates, FS1
Lodge, TP1
Hao, Y1
Chapovetsky, A1
Liu, JJ1
Welborn, M1
Luna, JM1
Do, T1
Haiges, R1
Miller Iii, TF1
Marinescu, SC1
Lopez, SA1
Compter, I1
Eekers, DBP1
Hoeben, A1
Rouschop, KMA1
Reymen, B1
Ackermans, L1
Beckervordersantforth, J1
Bauer, NJC1
Anten, MM1
Wesseling, P1
Postma, AA1
De Ruysscher, D1
Lambin, P1
Qiang, L1
Yang, S1
Cui, YH1
He, YY1
Kumar, SK1
Jacobus, SJ1
Cohen, AD1
Weiss, M1
Callander, N1
Singh, AK1
Parker, TL1
Menter, A1
Parsons, B1
Kumar, P1
Kapoor, P1
Rosenberg, A1
Zonder, JA1
Faber, E1
Lonial, S1
Anderson, KC1
Richardson, PG1
Orlowski, RZ1
Wagner, LI1
Rajkumar, SV1
Li, G1
Hou, G1
Cui, J1
Xie, H1
Sun, Z1
Fang, Z1
Dunstand-Guzmán, E1
Hallal-Calleros, C1
Hernández-Velázquez, VM1
Canales-Vargas, EJ1
Domínguez-Roldan, R1
Pedernera, M1
Peña-Chora, G1
Flores-Pérez, I1
Kim, MJ1
Han, C1
White, K1
Park, HJ1
Ding, D1
Boyd, K1
Rothenberger, C1
Bose, U1
Carmichael, P1
Linser, PJ1
Tanokura, M1
Salvi, R1
Someya, S1
Samuni, A1
Goldstein, S1
Divya, KP1
Dharuman, V1
Feng, J2
Qian, Y1
Cheng, Q1
Ma, H1
Ren, X1
Wei, Q1
Pan, W1
Guo, J1
Situ, B1
An, T1
Zheng, L1
Augusto, S1
Ratola, N1
Tarín-Carrasco, P1
Jiménez-Guerrero, P1
Turco, M1
Schuhmacher, M1
Costa, S1
Teixeira, JP1
Costa, C1
Syed, A1
Marraiki, N1
Al-Rashed, S1
Elgorban, AM1
Yassin, MT1
Chankhanittha, T1
Nanan, S1
Sorokina, KN1
Samoylova, YV1
Gromov, NV1
Ogorodnikova, OL1
Parmon, VN1
Ye, J1
Liao, W1
Zhang, P1
Nabi, M1
Cai, Y1
Li, F1
Alsbou, EM1
Omari, KW1
Adeosun, WA1
Asiri, AM1
Marwani, HM1
Barral, M1
Jemal-Turki, A1
Beuvon, F1
Soyer, P1
Camparo, P1
Cornud, F1
Atwater, BD1
Jones, WS1
Loring, Z1
Friedman, DJ1
Namburath, M1
Papirio, S1
Moscariello, C1
Di Costanzo, N1
Pirozzi, F1
Alappat, BJ1
Sreekrishnan, TR1
Volpin, F1
Woo, YC1
Kim, H1
Freguia, S1
Jeong, N1
Choi, JS1
Phuntsho, S1
Shon, HK1
Domínguez-Zambrano, E1
Pedraza-Chaverri, J1
López-Santos, AL1
Medina-Campos, ON1
Cruz-Rivera, C1
Bueno-Hernández, F1
Espinosa-Cuevas, A1
Bulavaitė, A1
Dalgediene, I1
Michailoviene, V1
Pleckaityte, M1
Sauerbier, P1
Köhler, R1
Renner, G1
Militz, H1
Costantini, AS1
Benvenuti, A1
Vineis, P1
Kriebel, D1
Tumino, R1
Ramazzotti, V1
Rodella, S1
Stagnaro, E1
Crosignani, P1
Amadori, D1
Mirabelli, D1
Sommani, L1
Belletti, I1
Troschel, L1
Romeo, L1
Miceli, G1
Tozzi, GA1
Mendico, I1
Maltoni, SA1
Miligi, L1
Vlaanderen, J1
Lan, Q1
Kromhout, H1
Rothman, N1
Vermeulen, R1
Galbraith, D1
Gross, SA1
Paustenbach, D1
Cogliano, VJ1
Baan, R1
Straif, K1
Infante, PF2
Rinsky, RA2
Hornung, RW2
Silver, SR2
Tseng, CY1
Cooper, SP1
Lai, D1
Glass, DC2
Sim, MR2
Fritschi, L1
Gray, CN2
Jolley, DJ2
Gibbons, C2
Kang, SK1
Lee, MY1
Kim, TK1
Lee, JO1
Ahn, YS1
Lincz, LF1
Scorgie, FE1
Robertson, R1
Enno, A1
Kirkeleit, J1
Riise, T1
Bråtveit, M1
Moen, BE1
Aksoy, M4
Erdem, S1
Dinçol, G1
Kutlar, A1
Bakioğlu, I1
Hepyüksel, T1
Rosner, F1
Grünwald, HW1
Decouflé, P1
Blattner, WA1
Blair, A1
Wong, O3
Herrinton, LJ1
Demers, PA1
Koepsell, TD1
Weiss, NS1
Daling, JR1
Taylor, JW1
Lyon, JL1
Swanson, GM1
Greenberg, RS1
Savitz, DA1
Andrews, KW1
Schnatter, AR1
Armstrong, TW1
Nicolich, MJ1
Thompson, FS1
Katz, AM1
Huebner, WW1
Pearlman, ED1
Ireland, B1
Collins, JJ1
Buckley, CF1
Riordan, SG1
Bezabeh, S1
Engel, A1
Morris, CB1
Lamm, SH1
Raabe, GK2
Lynge, E1
Anttila, A1
Hemminki, K1
Lundberg, I1
Milatou-Smith, R1
Nilsson, RI1
Nordlinder, R1
Hörte, LG1
Järvholm, B1
Bergsagel, DE1
Bergsagel, PL1
Alexanian, R1
Anderson, K1
Kyle, RA1
Goldstein, BD2
Shalat, SL1
Teitelbaum, DT1
Brautbar, N1
Schnatter, R1
Sonoda, T1
Nagata, Y1
Mori, M1
Ishida, T1
Imai, K1
Yardley-Jones, A1
Anderson, D1
Parke, DV1
Dinu, IV1
Hristea, R1
Potolsky, A1
Creger, WP1
Torres, A1
Giralt, M1
Raichs, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Case - Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China[NCT00559065]3,260 participants (Actual)Observational2006-07-11Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

13 reviews available for benzene and Multiple Myeloma

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Occupational benzene exposure and the risk of lymphoma subtypes: a meta-analysis of cohort studies incorporating three study quality dimensions.
    Environmental health perspectives, 2011, Volume: 119, Issue:2

    Topics: Benzene; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute;

2011
Benzene and human health: A historical review and appraisal of associations with various diseases.
    Critical reviews in toxicology, 2010, Volume: 40 Suppl 2

    Topics: Benzene; Female; History, 20th Century; History, 21st Century; Humans; Leukemia, Myeloid, Acute; Lym

2010
Updating IARC's carcinogenicity assessment of benzene.
    American journal of industrial medicine, 2011, Volume: 54, Issue:2

    Topics: Benzene; Carcinogens, Environmental; Congresses as Topic; Humans; International Agencies; Internatio

2011
The IARC october 2009 evaluation of benzene carcinogenicity was incomplete and needs to be reconsidered.
    American journal of industrial medicine, 2011, Volume: 54, Issue:2

    Topics: Benzene; Carcinogens, Environmental; Congresses as Topic; Humans; International Agencies; Internatio

2011
Cytotoxic drugs and leukaemogenesis.
    Clinics in haematology, 1980, Volume: 9, Issue:3

    Topics: Adult; Aged; Arsenic; Benzene; Bone Marrow; Breast Neoplasms; Female; Hodgkin Disease; Humans; Leuke

1980
Does benzene cause multiple myeloma? An analysis of the published case-control literature.
    Environmental health perspectives, 1996, Volume: 104 Suppl 6

    Topics: Benzene; Case-Control Studies; Gasoline; Humans; Hydrocarbons; Multiple Myeloma; Occupational Diseas

1996
Multiple myeloma and benzene exposure in a multinational cohort of more than 250,000 petroleum workers.
    Regulatory toxicology and pharmacology : RTP, 1997, Volume: 26, Issue:2

    Topics: Australia; Benzene; Benzene Derivatives; Canada; Carcinogens; Case-Control Studies; Chemical Industr

1997
Organic solvents and cancer.
    Cancer causes & control : CCC, 1997, Volume: 8, Issue:3

    Topics: Alcohol Drinking; Benzene; Biliary Tract Neoplasms; Carbon Tetrachloride; Carcinogens; China; Cohort

1997
Benzene and multiple myeloma: appraisal of the scientific evidence.
    Blood, 1999, Aug-15, Volume: 94, Issue:4

    Topics: Air Pollutants, Occupational; Benzene; Carcinogens; Environmental Exposure; Humans; Multiple Myeloma

1999
Meta-analysis of multiple myeloma and benzene exposure.
    Journal of epidemiology, 2001, Volume: 11, Issue:6

    Topics: Air Pollutants, Occupational; Benzene; Humans; Multiple Myeloma; Occupational Exposure; Risk Factors

2001
The toxicity of benzene and its metabolism and molecular pathology in human risk assessment.
    British journal of industrial medicine, 1991, Volume: 48, Issue:7

    Topics: Anemia, Aplastic; Animals; Benzene; Bone Marrow; Chemical Phenomena; Chemistry; Humans; Leukemia; Ma

1991
Is exposure to benzene a cause of human multiple myeloma?
    Annals of the New York Academy of Sciences, 1990, Volume: 609

    Topics: Benzene; Bone Marrow; Environmental Exposure; Humans; Incidence; Leukemia, Myeloid, Acute; Multiple

1990

Trials

2 trials available for benzene and Multiple Myeloma

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Genetic variations in benzene metabolism and susceptibility to multiple myeloma.
    Leukemia research, 2007, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzene; Case-Control Studies; Epoxide Hydrolases; Femal

2007

Other Studies

26 other studies available for benzene and Multiple Myeloma

ArticleYear
Risk of leukemia and multiple myeloma associated with exposure to benzene and other organic solvents: evidence from the Italian Multicenter Case-control study.
    American journal of industrial medicine, 2008, Volume: 51, Issue:11

    Topics: Adult; Aged; Benzene; Case-Control Studies; Female; Humans; Italy; Leukemia, Lymphoid; Male; Middle

2008
Benzene exposure and hematopoietic mortality: A long-term epidemiologic risk assessment.
    American journal of industrial medicine, 2002, Volume: 42, Issue:6

    Topics: Aged; Benzene; Cohort Studies; Female; Humans; Leukemia; Life Tables; Longitudinal Studies; Male; Mi

2002
Effect of follow-up time on risk estimates: a longitudinal examination of the relative risks of leukemia and multiple myeloma in a rubber hydrochloride cohort.
    American journal of industrial medicine, 2002, Volume: 42, Issue:6

    Topics: Benzene; Cohort Studies; Dose-Response Relationship, Drug; Humans; Leukemia; Longitudinal Studies; M

2002
Leukemia risk and relevant benzene exposure period-Re: follow-up time on risk estimates, Am J Ind Med 42:481-489, 2002.
    American journal of industrial medicine, 2004, Volume: 45, Issue:2

    Topics: Australia; Benzene; Case-Control Studies; Humans; Leukemia; Multiple Myeloma; Occupational Diseases;

2004
Health Watch exposure estimates: do they underestimate benzene exposure?
    Chemico-biological interactions, 2005, May-30, Volume: 153-154

    Topics: Air Pollutants, Occupational; Australia; Benzene; Case-Control Studies; Employment; Humans; Leukemia

2005
Occupational exposure to benzene in South Korea.
    Chemico-biological interactions, 2005, May-30, Volume: 153-154

    Topics: Adult; Air Pollutants, Occupational; Benzene; Biomarkers; Environmental Monitoring; Epidemiological

2005
Benzene exposure and multiple myeloma: a detailed meta-analysis of benzene cohort studies.
    Annals of the New York Academy of Sciences, 2006, Volume: 1076

    Topics: Benzene; Cohort Studies; Humans; Male; Multiple Myeloma; Occupational Exposure

2006
Increased risk of acute myelogenous leukemia and multiple myeloma in a historical cohort of upstream petroleum workers exposed to crude oil.
    Cancer causes & control : CCC, 2008, Volume: 19, Issue:1

    Topics: Benzene; Cohort Studies; Humans; Leukemia, Myeloid, Acute; Multiple Myeloma; Norway; Occupational Di

2008
Clinical observations showing the role of some factors in the etiology of multiple myeloma. A study in 7 patients.
    Acta haematologica, 1984, Volume: 71, Issue:2

    Topics: Adult; Antineoplastic Agents; Benzene; Female; Humans; Immunosuppressive Agents; Iodine Radioisotope

1984
Malignancies due to occupational exposure to benzene.
    Haematologica, 1980, Volume: 65, Issue:3

    Topics: Benzene; Humans; Leukemia; Lung Neoplasms; Lymphoma; Multiple Myeloma; Neoplasms; Occupational Disea

1980
Mortality among chemical workers exposed to benzene and other agents.
    Environmental research, 1983, Volume: 30, Issue:1

    Topics: Adult; Aged; Benzene; Chemical Industry; Humans; Leukemia; Male; Middle Aged; Multiple Myeloma; Neop

1983
Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene.
    Occupational and environmental medicine, 1995, Volume: 52, Issue:6

    Topics: Acute Disease; Benzene; Cohort Studies; Confidence Intervals; Humans; Leukemia, Myeloid; Multiple My

1995
Epidemiology of the M-component immunoglobulin types of multiple myeloma.
    Cancer causes & control : CCC, 1993, Volume: 4, Issue:2

    Topics: Benzene; Case-Control Studies; Environmental Exposure; Female; Humans; Immunoglobulin A; Immunoglobu

1993
Risk of myelogenous leukaemia and multiple myeloma in workers exposed to benzene.
    Occupational and environmental medicine, 1996, Volume: 53, Issue:5

    Topics: Benzene; Carcinogens; Humans; Leukemia, Myeloid; Multiple Myeloma; Occupational Diseases; Risk Facto

1996
Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers.
    Occupational and environmental medicine, 1996, Volume: 53, Issue:11

    Topics: Aged; Benzene; Canada; Case-Control Studies; Cause of Death; Histiocytic Disorders, Malignant; Human

1996
Cancer mortality among workers with benzene exposure.
    Epidemiology (Cambridge, Mass.), 1997, Volume: 8, Issue:3

    Topics: Benzene; Cause of Death; Chemical Industry; Cohort Studies; Confidence Intervals; Humans; Illinois;

1997
Mortality and cancer incidence among Swedish paint industry workers with long-term exposure to organic solvents.
    Scandinavian journal of work, environment & health, 1998, Volume: 24, Issue:4

    Topics: Adult; Aged; Air Pollutants, Occupational; Benzene; Cause of Death; Cohort Studies; Cross-Sectional

1998
Leukaemia, lymphoma, and multiple myeloma in seamen on tankers.
    Occupational and environmental medicine, 1998, Volume: 55, Issue:8

    Topics: Adult; Benzene; Case-Control Studies; Humans; Leukemia; Lymphoma; Male; Medical Record Linkage; Midd

1998
The casual relation between benzene exposure and multiple myeloma.
    Blood, 2000, Feb-15, Volume: 95, Issue:4

    Topics: Benzene; Environmental Exposure; Humans; Multiple Myeloma; Radiation, Ionizing

2000
Benzene and multiple myeloma: appraisal of the scientific evidence.
    Blood, 2000, May-01, Volume: 95, Issue:9

    Topics: Benzene; Carcinogens; Environmental Exposure; Humans; Multiple Myeloma; Research Design

2000
Petroleum worker studies and benzene risk assessment.
    Journal of toxicology and environmental health. Part A, 2000, Volume: 61, Issue:5-6

    Topics: Benzene; Carcinogens; Case-Control Studies; Extraction and Processing Industry; Humans; Leukemia; Ly

2000
Malignancies due to occupational exposure to benzene.
    American journal of industrial medicine, 1985, Volume: 7, Issue:5-6

    Topics: Adult; Benzene; Cholera Vaccines; Humans; Leukemia; Lung Neoplasms; Lymphoma; Middle Aged; Multiple

1985
Benzene as a leukemogenic and carcinogenic agent.
    American journal of industrial medicine, 1985, Volume: 8, Issue:1

    Topics: Benzene; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Multiple Myeloma; Occupational

1985
[Uranyl-resistant paraproteins. Immunochemical method of identification of pathological protein fractions].
    Medicina interna, 1970, Volume: 22, Issue:9

    Topics: Acetates; Arteriosclerosis Obliterans; Benzene; Blood Protein Disorders; Blood Proteins; gamma-Globu

1970
Radiation and drug therapies, and leukemia.
    Annual review of medicine, 1973, Volume: 24

    Topics: Antineoplastic Agents; Benzene; Bone Marrow Diseases; Chloramphenicol; Cyclophosphamide; Dose-Respon

1973
[Coexistence of chronic benzol contacts and multiple plasmacytoma. Presentation of 2 cases].
    Sangre, 1970, Volume: 15, Issue:2

    Topics: Adult; Benzene; Female; Humans; Immunoelectrophoresis; Immunoglobulin G; Male; Middle Aged; Multiple

1970